Sernova (TSE:SVA) Trading Up 6.7% – What’s Next?

Shares of Sernova Corp. (TSE:SVA) were up 6.7% on Tuesday . The company traded as high as C$0.16 and last traded at C$0.16. Approximately 103,406 shares traded hands during mid-day trading, a decline of 17% from the average daily volume of 124,361 shares. The stock had previously closed at C$0.15.

Sernova Stock Performance

The firm has a market cap of C$52.59 million, a PE ratio of -3.20 and a beta of 0.61. The business has a 50 day simple moving average of C$0.18 and a two-hundred day simple moving average of C$0.18. The company has a quick ratio of 18.11, a current ratio of 0.32 and a debt-to-equity ratio of -4.40.

Sernova Company Profile

Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem cells to create a bio-hybrid organ. A bio-hybrid organ refers to a medical device designed to be implanted into the human body, where it integrates with existing living tissue to replicate or enhance the function of a natural organ, essentially aiming to restore normal organ function by combining living cells with non-living materials to mimic the properties of the original organ and seamlessly interact with surrounding tissues.